An assay of deoxyadenosine and adenosine in human plasma by HPLC. 1980

C A Koller, and P L Stetson, and L D Nichamin, and B S Mitchell

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003070 Coformycin A ribonucleoside antibiotic synergist and adenosine deaminase inhibitor isolated from Nocardia interforma and Streptomyces kaniharaensis. It is proposed as an antineoplastic synergist and immunosuppressant.
D003839 Deoxyadenosines Adenosine molecules which can be substituted in any position, but are lacking one hydroxyl group in the ribose part of the molecule. Adenine Deoxyribonucleosides,Adenylyldeoxyribonucleosides,Deoxyadenosine Derivatives,Deoxyribonucleosides, Adenine,Derivatives, Deoxyadenosine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000241 Adenosine A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter. Adenocard,Adenoscan
D015649 Pentostatin A potent inhibitor of ADENOSINE DEAMINASE. The drug induces APOPTOSIS of LYMPHOCYTES, and is used in the treatment of many lymphoproliferative malignancies, particularly HAIRY CELL LEUKEMIA. It is also synergistic with some other antineoplastic agents and has immunosuppressive activity. 2'-Deoxycoformycin,CI-825,Co-Vidarabine,Deoxycoformycin,Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (R)-,NSC-218321,Nipent,2' Deoxycoformycin,CI 825,CI825,NSC 218321,NSC218321
D058892 Adenosine Deaminase Inhibitors Drugs that inhibit ADENOSINE DEAMINASE activity. ADA Inhibitors,Deaminase Inhibitors, Adenosine,Inhibitors, ADA,Inhibitors, Adenosine Deaminase

Related Publications

C A Koller, and P L Stetson, and L D Nichamin, and B S Mitchell
April 1998, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica,
C A Koller, and P L Stetson, and L D Nichamin, and B S Mitchell
February 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
C A Koller, and P L Stetson, and L D Nichamin, and B S Mitchell
January 1980, Advances in experimental medicine and biology,
C A Koller, and P L Stetson, and L D Nichamin, and B S Mitchell
March 1980, The Journal of clinical investigation,
C A Koller, and P L Stetson, and L D Nichamin, and B S Mitchell
March 1995, Journal of pharmaceutical and biomedical analysis,
C A Koller, and P L Stetson, and L D Nichamin, and B S Mitchell
January 1982, Cancer chemotherapy and pharmacology,
C A Koller, and P L Stetson, and L D Nichamin, and B S Mitchell
September 1998, Journal of pharmaceutical and biomedical analysis,
C A Koller, and P L Stetson, and L D Nichamin, and B S Mitchell
January 1989, Free radical biology & medicine,
C A Koller, and P L Stetson, and L D Nichamin, and B S Mitchell
January 1986, Advances in experimental medicine and biology,
Copied contents to your clipboard!